Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin

Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin

BackgroundWe compared the efficacies of vildagliptin (50 mg twice daily) relative to pioglitazone (15 mg once daily) as an add-on treatment to metformin for reducing glycosylated hemoglobin (HbA1c) levels in Korean patients with type 2 diabetes.MethodsThe present study was a multicenter, randomized,...

Full description

Bibliographic Details
Main Authors: Jong Ho Kim, Sang Soo Kim, Hong Sun Baek, In Kyu Lee, Dong Jin Chung, Ho Sang Sohn, Hak Yeon Bae, Mi Kyung Kim, Jeong Hyun Park, Young Sik Choi, Young Il Kim, Jong Ryeal Hahm, Chang Won Lee, Sung Rae Jo, Mi Kyung Park, Kwang Jae Lee, In Joo Kim
Format: Article
Language:English
Published: Korean Diabetes Association 2016-04-01
Series:Diabetes & Metabolism Journal
Subjects:
Dipeptidyl peptidase 4 inhibitor
Metformin
Thiazolidinediones
Online Access:https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-40-230.pdf

Internet

https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-40-230.pdf

Similar Items